STEREOTAXIS INC (STXS)
US85916J4094 - Common Stock
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort...
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical...
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort...
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Reports 2024 Third Quarter Financial Results
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Present at Upcoming Investor Conferences
ST. LOUIS, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
STXS Stock Earnings: Stereotaxis Misses EPS, Misses Revenue for Q2 2024
STXS stock results show that Stereotaxis missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Stereotaxis Reports 2024 Second Quarter Financial Results
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX....
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention,...
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
The most advanced robotic cardiac ablation lab opens at Penn Presbyterian Medical Center. ...
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices....
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy....
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
Stereotaxis presents innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablati...
STXS Stock Earnings: Stereotaxis Meets EPS, Misses Revenue for Q1 2024
STXS stock results show that Stereotaxis met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Stereotaxis Reports 2024 First Quarter Financial Results
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024
Stereotaxis will host first-quarter financial results on May 13, 2024. ...
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
7 Penny Stocks That Could 5X by the End of 2024
These seven penny stocks to buy have the potential to 5X your money by the end of 2024 if the right catalysts unfold.
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Although lesser-known ideas present high risks, these cheap stocks under $10 could be intriguing for the calculating speculator.
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Reports 2023 Full Year Financial Results
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
Intermountain Medical Center becomes the first hospital in the Intermountain region and in Utah to adopt the latest in robotic heart care technology. ...
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...
Stereotaxis Announces First Patients Successfully Treated Using MAGiC Ablation Catheter
Stereotaxis announces first patients treated using new Magnetic Interventional Catheter, MAGiC...